Literature DB >> 2915230

T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

J P Malin1, R Ködding, H Fuhrmann, A von zur Mühlen.   

Abstract

Thyronine (T4), triiodothyronine (T3), and reverse-triiodothyronine (rT3) levels were evaluated in cerebrospinal fluid (CSF) and in serum of 12 patients with definite amyotrophic lateral sclerosis (ALS) by specific radioimmunoassays. Circulating microsomal and thyroglobulin antibodies were also evaluated. In all patients serum levels of T4, T3 and rT3 were within normal limits. In CSF, the rT3 levels were significantly elevated to 0.118 micrograms/l (mean), the T4 levels were not significantly elevated, and the T3 levels were below the detection limit of 0.03 micrograms/l. A correlation between the elevated rT3 levels in CSF and the severity or type of ALS could not be demonstrated by this study. The antithyroid antibodies (thyroglobulin antibodies, microsomal antibodies) showed normal titres and did not suggest disturbances of thyroid autoimmunity in the patients with ALS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915230     DOI: 10.1007/BF00314221

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.

Authors:  M M Kaplan; J A Taft; S Reichlin; T L Munsat
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

2.  Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid.

Authors:  I M Jackson; L S Adelman; T L Munsat; S Forte; R M Lechan
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

3.  Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.

Authors:  H Mitsumoto; E D Salgado; D Negroski; M R Hanson; V D Salanga; J F Wilber; A J Wilbourn; A C Breuer; J Leatherman
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

4.  Thyroid function in 44 patients with amyotrophic lateral sclerosis.

Authors:  W R Kiessling
Journal:  Arch Neurol       Date:  1982-04

5.  Letter: Reverse triiodothyronine in liver disease.

Authors:  R Kodding; J Janzen; E Schmidt; R D Hesch
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

6.  Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis.

Authors:  J S Mora; T L Munsat; K P Kao; L J Finison; W Hedlund; G A Bradley; R Scheife; J A Georgiades
Journal:  Neurology       Date:  1986-08       Impact factor: 9.910

7.  Motor neurone disease and hyperthyroid Graves' disease: a chance association?

Authors:  J McMenamin; M Croxson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-01       Impact factor: 10.154

8.  Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.

Authors:  W K Engel; T Siddique; J T Nicoloff
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

9.  Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations.

Authors:  S H Appel; V Stockton-Appel; S S Stewart; R H Kerman
Journal:  Arch Neurol       Date:  1986-03

10.  Iodothyronine levels in human cerebrospinal fluid.

Authors:  P Thompson; K D Burman; F D Wright; M W Potter; L Wartofsky
Journal:  J Clin Endocrinol Metab       Date:  1982-03       Impact factor: 5.958

View more
  3 in total

1.  An exploratory study of the association between thyroid hormone and survival of amyotrophic lateral sclerosis.

Authors:  Zhenzhen Zheng; Xiaoyan Guo; Rui Huang; Xueping Chen; Huifang Shang
Journal:  Neurol Sci       Date:  2014-02-07       Impact factor: 3.307

2.  Amyotrophic lateral sclerosis and thyroid function.

Authors:  Y Iwasaki; M Kinoshita; K Ikeda; K Takamiya; T Shiojima
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

Review 3.  Thyroid dysfunction in Portuguese amyotrophic lateral sclerosis patients.

Authors:  Cláudia Santos Silva; Marta Gromicho; Miguel Oliveira Santos; Susana Pinto; Michael Swash; Mamede de Carvalho
Journal:  Neurol Sci       Date:  2022-05-27       Impact factor: 3.830

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.